Suximidium (Epilepsy = ALL)

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias

Empty. There are no case-control studies available for this drug.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Czeizel (Suximidium)
1992
Hungary
1980 - 1987
case control
The Hungarian Case-Control Surveillance of Congenital Anomalies. Children affected with congenital abnormalities born from treated or untreated mothers. Children without congenital abnormalities born from treated or untreated mothers. Mothers were mailed a questionnaire requested information on medicinal products taken during pregnancy and to send their prenatal maternity logbook which related drug prescriptions. Regional nurses were asked to visit and question the non-respondent. throughout pregnancy 100 / 54 The study design was partly completed thanks to the reference [6] cited in the publication (as the definition of congenital abnormalities).
Notification of cases with congenital abnormality is mandatory for physicians to the HCAR. Pathologists sent autopsy report for stillbirths and infant deaths cases. Prenatally diagnosed and electively terminated malformed fetuses have also been registered.

Risk of bias: : NA;   : low;   : moderate;   : serious;   : critical;   : unclear;  

master protocol